Bing-Liang Lin
Overview
Explore the profile of Bing-Liang Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu L, Li X, Deng K, Lin B, Deng H, Xie D, et al.
Liver Res
. 2025 Feb;
7(2):136-144.
PMID: 39958952
Background And Aims: The primary goal of chronic hepatitis B (CHB) treatment is to reduce hepatitis B surface antigen (HBsAg). T helper 17 (Th17) and regulatory T (Treg) cells are...
2.
Cai M, Chen D, Chen X, Gu Y, Liao C, Xiao L, et al.
Cell Oncol (Dordr)
. 2024 Jul;
47(5):1897-1910.
PMID: 39080215
Background: Liver cancer stem cells (CSCs) contribute to tumor initiation, progression, and recurrence in hepatocellular carcinoma (HCC). The Wnt/β-catenin pathway plays a crucial role in liver cancer stemness, progression, metastasis,...
3.
Zhang X, Li S, Gu Y, Xiao L, Ma X, Chen X, et al.
Mol Cancer
. 2024 May;
23(1):113.
PMID: 38802795
Background: The role of circRNAs in hepatocellular carcinoma (HCC) progression remains unclear. CircPIAS1 (circBase ID: hsa_circ_0007088) was identified as overexpressed in HCC cases through bioinformatics analysis. This study aimed to...
4.
Lei Z, Li Z, Lin D, Cao J, Chen J, Meng S, et al.
Cell Biosci
. 2024 Apr;
14(1):54.
PMID: 38678227
Background: Extensive hepatocyte mortality and the absence of specific medical therapy significantly contribute to the unfavorable prognosis of acute liver failure (ALF). Ferroptosis is a crucial form of cell death...
5.
Li Z, Wang J, Li X, Meng S, Zheng H, Wang J, et al.
Genomics
. 2023 Nov;
115(6):110737.
PMID: 37926353
Background: Acute-on-chronic liver failure (ACLF) is a major challenge in the field of hepatology. While mesenchymal stem cell (MSC) therapy can improve the prognosis of patients with ACLF, the molecular...
6.
Li Z, Chen J, Zhang J, Lei Z, Wu L, Meng S, et al.
Stem Cells
. 2023 Sep;
41(12):1171-1184.
PMID: 37659098
Acute-on-chronic liver failure (ACLF) is a severe disease with a high mortality. Macrophage-related inflammation plays a crucial role in ACLF development. Mesenchymal stem cells (MSCs) treatment was demonstrated to be...
7.
Chen J, Weng W, Huang M, Peng X, Zhang J, Xiong J, et al.
BMC Gastroenterol
. 2022 Jul;
22(1):330.
PMID: 35799116
Background: Thyroid dysfunction has been reported in severe liver diseases. The aim of this study was to analyze the impact of serum thyroid-stimulation hormone (TSH) levels on the prognosis of...
8.
Weng W, Chen J, Peng X, Huang M, Zhang J, Xiong J, et al.
Epidemiol Infect
. 2022 Jul;
150:e147.
PMID: 35788251
Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a severe and life-threatening complication, characterised by multi-organ failure and high short-term mortality. However, there is limited information on the impact of...
9.
Chen J, Chen S, Lei Z, Cao H, Zhang S, Weng W, et al.
Hepatol Int
. 2022 May;
16(4):775-788.
PMID: 35616850
Background/purpose Of The Study: Mortality from hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is high. Severe infection is the most important complication that affects the outcomes of ACLF patients....
10.
Liu J, Lei Z, Pang Y, Huang Y, Xu L, Zhu J, et al.
World J Clin Cases
. 2021 Jul;
9(20):5621-5630.
PMID: 34307617
Background: () belongs to the group of rapidly growing . This microorganism is associated with a wide spectrum of infectious diseases. Due to a low detection rate or the time...